Diabetes Mellitus
Thyroid
Adrenals
Calcium and bone disorders
Reproductive medicine
100

Diagnosis of Diabetes?

Hemoglobin A1c >/= 6.5%, fasting plasma glucose>126mg/dl, or 2-hour plasma glucose after a 75-gram carbohydrate challenge during an oral glucose tolerance test >200mg/dl, or RPG >200mg/dl

100

Most sensitive thyroid function test?

TSH

100

What are the functional zones of the adrenal gland? 

Zona glomerulosa (mineralocorticoid), zona fasciculata (glucocorticoid), zona reticularis (DHEA - only significant in women)

Adrenal medulla - catecholamines

100

How is osteoporosis diagnosed clinically and on DEXA?

Osteoporosis can be diagnosed clinically based on fragility fractures, hip fracture, vertebral compression fracture, or a bone mineral density (T score) measurement of ≤−2.5.

100

Most common cause of primary amenorrhea?

Turner's Syndrome (XO)

200

Lifestyle modification recommendations from the diabetes prevention program for patients with pre-diabetes?

ADA recommends the DPP goals of 7% weight loss over 6 months and at least 150 min/week of moderate-intensity exercise to reduce the risk of diabetes development.

200

True or false, measurement of T3 is helpful in hypothyroidism?

False, Measurement of triiodothyronine in the setting of hypothyroidism is not necessary or recommended; normal levels are maintained unless hypothyroidism is severe.

t3 is useful in (1) in the evaluation of thyrotoxicosis to identify isolated T3 toxicosis, (2) to assess the severity of hyperthyroidism and response to therapy, and (3) potentially, to differentiate hyperthyroidism from destructive thyroiditis. 

200

Initial testing for cushing's syndrome?

Overnight dexamethasone suppression test, salivary cortisol or 24hr urinary cortisol

200

Most appropriate test for to assess for vitamin D stores during assessment of vitamin D deficiency?

25-Hydroxyvitamin D is the storage form of vitamin D in the body, and measurement of 25-hydroxyvitamin D is the most appropriate test for assessing vitamin stores.

200

Criteria for diagnosis of PCOS?

After ruling out other causes;

2 of 3 - 

1 Oligo/anovulation

2 Clinical or biochemical signs of hyperandrogenism

3 Polycystic ovaries on ultrasound

300

3 Antibodies that can be present in Type 1 Diabetes?

Glutamic acid decarboxylase (GAD65), tyrosine phosphatases IA-2 and IA-2β, islet cells, insulin, and zinc transporter (Zn T-8). Owing to highly automated available assays, GAD65 and IA-2 autoantibodies are recommended for initial screening. GAD65 autoantibodies have a high prevalence (70%) at the time of diagnosis and may remain detectable for years.

300

Initial treatment dose of levothyroxine in uncomplicated geriatric patients with hypothyroidism?

25-50 µg/day

300

Cut off for abnormal test when evaluating for primary aldosteronism?

Renin/aldosterone ratio >20 or aldosterone level >15

300

Medications that cause hypercalcemia?

Hydrochlorothiazide, lithium, vitamin D and vitamin A intoxication 

300

What is the criteria to evaluate a couple for infertility?

Infertility evaluation is appropriate after 1 year of unprotected intercourse in women younger than age 35 years and after 6 months in women age 35 years or older.

400

Recommended second line therapy for T2DM after metformin in patients with established ASCVD, high risk for ASCVD, CKD or heart failure?

GLP 1 agonists or SGLT2 inhibitors (liraglutide and empagliflozin have stronger evidence)

400

For a newly pregnant patient with hypothroidism, who is in the first trimester, and is currently euthyroid, should her levothyroxine dose be:

1 - Increased by 30%

2 - Decreased by 30%

3 - Unchanged

4 - Stopped, and liothyronine started

1 - Increased by 30%

400

Treatment steps once pheochromocytoma has been diagnosed

1. alpha blockade (phenoxybenzamine or doxasozin)

2. Beta blockade

3. Surgery

400

Indications for surgery in primary hyperparathyroidism?

Calcium lvl >1mg/dl above normal

Osteoporosis or fragility fracture

Nephrolithiasis

Urine calcium >400mg/ml/day

CrCl <60 mL/min

400

In PCOS, name one treatment for each:

1. Hirsutism and menstrual dysfunction

2. Fertility

1. OCPs, weight loss, anti androgens such as spironolactone or Topical eflornithine (for hair growth), also metformin

2. Clomiphene citrate or letrozole 

500

Options to reverse hypoglycemia unawareness? (a.k.a. asymptomatic hypoglycemia in patients with diabetes)

Lowering insulin doses, Continuous glucose monitor with alarm, some evidence to suggest islet cell transplants (done more regularly in the UK)

500

Treatment for Graves ophthalmopathy? (bonus for more than one answer)

Steroids, or teprotumumab, or even surgery 

500

Treatment of choice in primary adrenal insufficiency?

1. Dexamethasone twice daily

2. Hydrocortisone twice daily

3. Hydrocortisone twice daily and fludrocortisone once daily

4. Prednisone twice daily

5. Prednisone twice daily and fludrocortisone once daily 

3. Hydrocortisone twice daily and fludrocortisone once daily


(prednisone is once daily)

500

2 alternatives to bisphosphonates in osteoporosis, and their method of action.

Denosumab is a monoclonal antibody that inhibits osteoclast activation via RANK Ligand Inhibition

Teriparatide is recombinant PTH which stimulates bone growth rather than inhibit.

500

A 34-year-old transgender woman is evaluated during a routine examination. She desires gender-affirming hormone therapy. Her gender incongruence diagnosis has been made and confirmed by qualified medical providers. She smokes one pack of cigarettes per day, with a 15-pack-year history. Medical history is otherwise unremarkable. She takes no medications.

On physical examination, vital signs are normal. She has male hair distribution. Normal male genitalia are present. There are no evident inguinal hernias.

In addition to advising smoking cessation, which of the following is the most appropriate next step in management?

1. Initiation of an androgen blocker

2. Initiation of estradiol therapy

3. Refer for gender confirmation surgery consultation

4. Refer for discussion on fertility preservation options

5. Return for treatment 1 year after living in desired gender role 

4. Refer for discussion on fertility preservation options

Because gender-affirming hormone therapy limits fertility, reproductive options should be discussed with patients prior to initiation.

M
e
n
u